Unilabs

Understanding genetic factors in hereditary cancer helps tailor proactive management and preventive measures, aiming for the best possible patient outcomes and support. Some cancers have a stronger genetic predisposition, with hereditary syndromes making up around 3-20% of all cancer cases. Unilabs provides oncogenetic consultations which can unlock possible risk-reducing interventions and provide informed clinical decisions for the patient. Developments in next-generation sequencing allow us to quickly analyse multiple genes at once, helping identify harmful gene changes linked to hereditary cancers. Additionally, new treatments like PARP inhibitors and checkpoint inhibitors show promise for cancers with specific genetic mutations.  Learn more from Unilabs' Oncogenetics specialist Dr Zuzana Mazerikova.  https://lnkd.in/eN_vp_64 #Genetics #Oncology #Cancer #Healthcare 

Lung cancer is one of the most common and deadliest cancers globally.    Following World Lung Cancer Day, Unilabs highlights the importance of continuing to raise awareness and empowering those affected by this devastating disease. To shed light on the current landscape of lung cancer, we had the opportunity to sit down with Matthew Ginder, Unilabs’ TMC Head of Business Unit UK, who brings a wealth of knowledge and experience in this field.     Matthew gives insights into the critical aspects of lung cancer, emphasising the importance of early detection and the collective efforts needed to combat this illness. Read on to learn more about these topics, along with the groundbreaking research Unilabs is leading on early diagnosis through the UK's national lung health check programme.     #WorldLungCancerDay #Cancer #HealthCare 

In this interview with Dr Carlos Mendes, Clinical Pathology Medical Specialist at Unilabs, we explore the diverse spectrum of blood cancers, including leukaemia and myelodysplastic syndromes, and the significant role of a multi-disciplinary approach combining clinical, laboratory and genomic data to ensure a holistic care approach. He also looks at advancements in the sensitivity and specificity of lab tests which are revolutionising the field. Read the full interview in our blog here: https://lnkd.in/efzdhYN7 #Cancer #BloodCancerAwarenessMonth #HealthCare 

A major milestone for brain health diagnostics and research across Europe and beyond. We’re proud to share Unilabs has entered a multi-year partnership with C2N Diagnostics, LLC (“C2N”), a pioneer in advanced diagnostic solutions for Alzheimer’s disease and related neurological disorders. The partnership will expand reach of C2N’s Precivity™ Blood Tests in over 75 countries to transform early diagnosis and research of Alzheimer’s disease, with plans to facilitate a technology transfer of C2N’s proprietary portfolio of Alzheimer’s blood biomarkers to deliver a Unilabs testing network across Europe, including Norway and Switzerland, and the United Kingdom. The agreement will also provide access in Peru, Saudi Arabia, and the United Arab Emirates beyond existing C2N partnerships.    C2N and Unilabs expect the Precivity™ portfolio of blood tests will become available to Unilabs customers over the coming months, depending on geographic region. Tests will only be available for order by qualified healthcare providers. We are confident these tests can help in achieving better outcomes for patients, as we continue in our mission to power health and maximise life. Find out more: https://lnkd.in/gfW_4MCy #Alzheimers #Healthcare #PublicHealth #MedicalResearch  

Our commitment to improving patient care and treatment drives us to continually explore new ways to support healthcare practitioners and patients. Explore the latest news from our specialist global pathology, laboratory and imaging teams: 💯 In May the Journal of Personalised Medicine published our contribution to a meticulous analysis of lung cancer patient pathways in the Portuguese healthcare system, identifying several areas for enhancement and comprehensive proposals to address them. Read the paper: https://lnkd.in/eupdJKcT  👩⚕️ Led by Dr Mariana Costa, in March we joined one of the world’s foremost international HPV-related congresses, EUROGIN Conference Conference, to present pioneering research on the potential of DNA methylation to transform cervical cancer screening. A showcase of how our leading laboratories and cross-country partnerships can help healthcare providers unlock faster treatment and reduce healthcare costs. Learn more about our ongoing areas of HPV research here: https://lnkd.in/e_QPpiNm 🤝 We announced plans in May to expand our collaboration with Clínica Good Hope, increasing access to Unilabs sites in Peru for laboratory sample collection and imaging tests across the region. Learn about the new standards we’ve set for diagnostic accuracy and efficiency of turnaround time (TAT) through the partnership: https://lnkd.in/ewu6EaSk 👀 Distinguished Unilabs pathologist and a member of the Swiss Society of Pathology, Dr Hohl, marked Skin Cancer Awareness month with an interview outlining the advancements in diagnostic technology that are leading to considerable progress in the understanding and earlier detection of melanoma. View: https://lnkd.in/e66Fzuj4  🚀 Unilabs AI Project manager, Tomasz Stankiewicz, unpacked the transformative power of AI to augment pathologists' capabilities. AI offers significant opportunities to assist clinicians, according to Stankiewicz. Learn more about our approach to critical considerations in AI application in areas like radiology:  https://lnkd.in/gYNsSSEV Missed these updates? Be sure to follow us, and catch up across more on our website: https://lnkd.in/eSVTcyzj #HealthCare #Diagnostics #Radiology #Pathology

Non-invasive prenatal screening (NIPT) is one of the latest genetic diagnostic tools offered by Unilabs that is transforming approaches to prenatal care. Unilabs medical genetics specialist and laboratory manager, RNDr Renáta Zemjarová Mezenská, explores its applications and other critical diagnostic tests that can support individuals and families throughout their reproductive journey in our latest interview: https://lnkd.in/gzwxcJAY  #Genetics #Genomics #HealthCare #Diagnostics 

Genetic tests can lead to important life-altering decisions. Genetic counsellors ensure that patients are never alone in this journey, providing crucial support along the way.      From the initial consultation to receiving test results, genetic counsellors provide patients with empathy and support, helping them feel prepared and empowered in their journey.      Ahead of International Self-Care day we spoke with Marie Met-Domestici, a seasoned genetic counsellor at Unilabs Switzerland, to learn more about how genetic counselling can support self-care and personal health management by empowering patients to take proactive steps towards a healthier future.     Find out more in our latest interview:  https://lnkd.in/gNqWYD_d    #Genetics #SelfCare #Wellness #Health  

We are delighted to announce that Thomas Lindahl has been appointed to the role of Chief Medical Officer, Unilabs. This appointment is the latest in a long line of successful leadership roles at the company for Thomas, who was most recently Unilabs’ Medical Director, Radiology. Thomas’ new role sees him join the Unilabs Executive team, to which he brings a wealth of experience from both the medical field — specifically in radiology — as well as from across several of Unilabs’ markets. His passion for advancing healthcare through world-leading medical diagnostics and health tech, coupled with his commitment to integrating diverse perspectives to enhance diagnostic accuracy and care, will be key to our efforts to power health and maximise life. Read more here: https://lnkd.in/ed23vXGF #Unilabs #Leadership #HealthTech

Pollen season is in full swing, and the Unilabs team in Sweden is supporting a national programme of pollen level monitoring to help communities stay informed.    This World Allergy Day, we caught up with Susanne Fröjdendal at Unilabs' microbiology lab in Mälarsjukhuset, Eskilstuna to learn about the sophisticated pollen trap she overseas at one of the 22 pollen stations across Sweden. Mimicking human breathing, it captures and analyses the air's pollen content providing data to produce a pollen forecast, factoring weather patterns and flowering progress.    "Predicting future changes in pollen patterns is a complex task that involves multiple factors." says Fröjdendal. "We can see that the amount of pollen has increased by 10-20%, which puts a higher burden on people with allergies. We continuously monitor and collect data on pollen levels, so we can help anticipate changes and inform the public in a timely manner.” Learn more in our latest interview: https://lnkd.in/etNWSEki    #WorldAllergyDay #HealthCare #Research #Environment

Sarcomas, a diverse group of malignancies with over 50 subtypes, require specialised expertise for accurate diagnosis and treatment. Often evading early detection due to their rarity and varied presentation, understanding them demands deep knowledge and extensive experience. This Sarcoma Awareness Month, we interviewed Unilabs sarcoma imaging expert Dr Björn Jobke to discuss the role of advanced imaging techniques in diagnosis, and the importance of a multimodal treatment approach to avoid unnecessary invasive procedures.   "I remember a case from my time as a resident in Bone Pathology when we received a resected femoral head (the ‘ball’ at the top of the thigh bone) from a younger patient with uncontrollable hip pain," says Dr Jobke. "After a thorough investigation of the specimen, the patient turned out to have a tiny (3mm) benign tumour, known to cause severe pain. If identified earlier with dedicated imaging review and expertise, the patient could have avoided a hip replacement which is a life-changing, invasive procedure and been treated definitively with a minimally invasive technique.”   Learn more about sarcoma types, the diagnosis approach and developments in sarcoma radiology and care: https://lnkd.in/eJurWffP #Diagnostics #Cancer #Healthcare